KR850004391A - 비-수성 아이버멕틴 제형 - Google Patents

비-수성 아이버멕틴 제형 Download PDF

Info

Publication number
KR850004391A
KR850004391A KR1019840008224A KR840008224A KR850004391A KR 850004391 A KR850004391 A KR 850004391A KR 1019840008224 A KR1019840008224 A KR 1019840008224A KR 840008224 A KR840008224 A KR 840008224A KR 850004391 A KR850004391 A KR 850004391A
Authority
KR
South Korea
Prior art keywords
dissolved
propylene glycol
mixture
ivermectin
mentioned
Prior art date
Application number
KR1019840008224A
Other languages
English (en)
Other versions
KR880002366B1 (ko
Inventor
비. 윌리암스 제임스
Original Assignee
제임스 에프. 노톤
머크 앤드 캄파니, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제임스 에프. 노톤, 머크 앤드 캄파니, 인코포레이티드 filed Critical 제임스 에프. 노톤
Publication of KR850004391A publication Critical patent/KR850004391A/ko
Application granted granted Critical
Publication of KR880002366B1 publication Critical patent/KR880002366B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

비-수성 아이버멕틴 제형
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 프로필렌 글리콜과 글리세롤 포름알 또는 물과의 혼합물에 용해된 애버멕틴 또는 밀베마이신으로 이루어진 내부 및 외부 구충제 비경구 제형.
  2. 제1항에 있어서, 언급된 애버멕틴 또는 밀베마이신 화합물이 아이버멕틴인 제형.
  3. 제2항에 있어서, 언급된 아이버멕틴이 글리세를 포름알과 프로필렌 글리콜과의 혼합물에 용해된 제형.
  4. 제3항에 있어서, 언급된 아이버멕틴이 0.1 내지 20%W/V로 존재하며, 글리세를 포름알과 프로필렌 글리콜과의 10:90 내지 90:10V/V비의 혼합물에 용해된 재형.
  5. 제4항에 있어서, 언급된 아이버멕틴이 약 1%W/V로 존재하고, 약 40:60의 비로 용매에 용해된 제형.
  6. 제2항에 있어서, 언급된 아이버멕틴이 프로필렌글리콜과 물과의 혼합물에 용해된 제형.
  7. 제6항에 있어서, 언급된 아이버멕틴이 0.1 내지 20%W/V로 존재하고, 프로필렌 글리콜과 물과의 95:5 내지 80:20V/V비의 혼합물에 용해된 제형.
  8. 제7항에 있어서, 언급된 아이버멕틴이 약 1%W/V로 존재하고, 약 90:10의 비로 용매에 용해된 제형.
  9. 애버멕틴을 충분량의 글리세를 포름알, 프로필렌 글리콜 또는 이들의 혼합물에 용해시키고, 용매 농도를 목적치로 조절하는 것으로 이루어짐을 특징으로 하는, 프로필렌 글리콜과 글리세를 포름알 또는 물과의 혼합물에 용해된 애버멕틴 또는 밀베마이신으로 이루어진 내부 및 외부구충제 비경구 제형의 제조방법.
  10. 애버멕틴을 충분량의 프로필렌 글리콜에 용해시키고, 필요량의 물을 첨가시킨 다음, 프로필렌 글리콜을 사용하여 농도를 목적치로 조절하는 것으로 이루어짐을 특징으로 하는, 프로필렌 글리콜과 글리세를 포름알 또는 물과의 혼합물에 용해된 애버멕틴 또는 밀베마이신으로 이루어진 내부 및 외부구충제 비경구 제형의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840008224A 1983-12-22 1984-12-21 비-수성 아이버멕틴 제제 KR880002366B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56414083A 1983-12-22 1983-12-22
US564,140 1983-12-22
US564140 2000-05-03

Publications (2)

Publication Number Publication Date
KR850004391A true KR850004391A (ko) 1985-07-15
KR880002366B1 KR880002366B1 (ko) 1988-11-03

Family

ID=24253315

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840008224A KR880002366B1 (ko) 1983-12-22 1984-12-21 비-수성 아이버멕틴 제제

Country Status (17)

Country Link
EP (1) EP0146414B1 (ko)
JP (1) JPH0623100B2 (ko)
KR (1) KR880002366B1 (ko)
AT (1) ATE47522T1 (ko)
AU (1) AU560864B2 (ko)
CA (1) CA1267844A (ko)
DE (1) DE3480263D1 (ko)
DK (1) DK164772C (ko)
ES (1) ES8608888A1 (ko)
GR (1) GR81244B (ko)
HK (1) HK5091A (ko)
IE (1) IE57681B1 (ko)
IL (1) IL73800A (ko)
NZ (1) NZ210505A (ko)
PT (1) PT79656B (ko)
SG (1) SG97890G (ko)
ZA (1) ZA849841B (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058244T3 (es) * 1987-01-23 1994-11-01 Pfizer Procedimiento para produccion de avermectinas y cultivos para el mismo.
US5075307A (en) * 1987-07-28 1991-12-24 Merck & Co., Inc. Paraherquamide and dihydroparaherquamide as antihelminthic agents
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
GB2275193A (en) * 1993-02-17 1994-08-24 Merck & Co Inc Formulations for the topical delivery of avermectins
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
SI9420028A (en) * 1993-05-10 1996-06-30 Merck & Co Inc Pour-on medical formulations containing avermectin compound as a medical active agent, polymeric material, glycols and glycerides
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
ZA981925B (en) * 1997-03-21 1998-10-23 Biogenesis S A A long acting injectable parasiticidal composition and the process for its preparation
UY25089A1 (es) * 1997-07-10 2000-08-21 Hoechst Roussel Vet Gmbh Vacunas no acuosas
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
AU7463000A (en) * 1999-09-22 2001-04-24 Ashmont Holdings Limited Sheep pour-on
JP2001253824A (ja) * 2000-03-14 2001-09-18 Mitsukazu Matsumoto 局所注射用処方剤
GR1003969B (el) * 2001-02-05 2002-08-14 U��-Pharma ����� ������ ������������ ���������� ���� Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
US20050009762A1 (en) 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
JP4886214B2 (ja) * 2005-05-24 2012-02-29 日本パワーファスニング株式会社 石膏ボード締結用の２条式木ねじ
PT2331068T (pt) 2008-10-08 2017-03-13 Zoetis Services Llc Composições anti-helmínticas de benzimidazol
JP5607114B2 (ja) 2012-06-26 2014-10-15 株式会社トープラ タッピンねじ
EP4337015A1 (en) 2021-05-14 2024-03-20 Syngenta Crop Protection AG Insect, acarina and nematode pest control
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4130651A (en) * 1978-03-31 1978-12-19 American Cyanamid Company Butamisole injectable formulations having improved margin of safety in dogs
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
US4430329A (en) * 1982-05-17 1984-02-07 Merck & Co., Inc. Synergistic treatment of adult canine heartworm with thiacetarsamide and ivermectin

Also Published As

Publication number Publication date
NZ210505A (en) 1988-06-30
JPS60169415A (ja) 1985-09-02
AU560864B2 (en) 1987-04-16
JPH0623100B2 (ja) 1994-03-30
DK164772C (da) 1993-01-04
HK5091A (en) 1991-01-18
SG97890G (en) 1991-02-14
GR81244B (en) 1985-04-16
ES538750A0 (es) 1986-07-16
ATE47522T1 (de) 1989-11-15
PT79656B (en) 1987-01-16
IL73800A0 (en) 1985-03-31
PT79656A (en) 1985-01-01
AU3702484A (en) 1985-07-04
EP0146414A2 (en) 1985-06-26
IE843221L (en) 1985-06-22
CA1267844A (en) 1990-04-17
DK164772B (da) 1992-08-17
ZA849841B (en) 1986-07-30
EP0146414A3 (en) 1986-12-10
KR880002366B1 (ko) 1988-11-03
ES8608888A1 (es) 1986-07-16
IL73800A (en) 1987-11-30
EP0146414B1 (en) 1989-10-25
DK619784A (da) 1985-06-23
IE57681B1 (en) 1993-02-24
DK619784D0 (da) 1984-12-21
DE3480263D1 (en) 1989-11-30

Similar Documents

Publication Publication Date Title
KR850004391A (ko) 비-수성 아이버멕틴 제형
ATE53301T1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
NO883162D0 (no) Blanding og anvendelse.
EP0181166A3 (en) Solubilised platinum compounds
KR880002524A (ko) 니코란딜 외용제
FR2548676B1 (fr) Compositions de biopolymeres et leur procede de preparation
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
JPS52107045A (en) Stable aqueous emulsions of acrylonitrile polymers, their preparation, and dyeability improvers therefrom
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
JPS5299217A (en) Vermin attractants
KR840004498A (ko) 상승작용성 아버멕틴 조성물 및 절지동물을 처리하는 방법
ES2037740T3 (es) Formulacion ectoparasiticida no acuosa para aplicar en liquido por el sistema "pour on".
JPS5212256A (en) Halogen-containing resin compositions
KR840006657A (ko) 이소퀴놀린 화합물의 제조방법
JPS57212243A (en) Preventing method for formation of nitrosamine in rubber
JPS5334764A (en) Preparation of diterpene derivatives and their preparation
KR850001228A (ko) (8s)-8-플루오로에리트로마이신의 제조방법
JPS5432487A (en) Preparation of 1-carbamoyluracils
KR910009258A (ko) 니트록시닐과 레바미솔 복합주사제의 제조방법
KR890005002A (ko) 방수 콘크리이트 제조용 배합제
JPS5340742A (en) Prostagilandin analogues, their preparation and medical composition containing the same as active constituents
JPS5627650A (en) High-titer karl fischer reagent
JPS5550072A (en) Aqueous ink composition
JPS5344597A (en) Condensed quinazolinol derivative
JPS52115848A (en) One-pack type, curable high polymer composition

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20041011

Year of fee payment: 17

EXPY Expiration of term